NTES-S
09999
JD HEALTH
06618
TRIP.COM-S
09961
JD-SW
09618
BABA-W
09988
(Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | (FY)Mar 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -66.64%152.18M | ---- | -26.12%456.22M | ---- | 320.94%617.52M | ---- | -53.15%146.7M | ---- | 3.66%313.1M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | 26.78%-2.34M | ---- | -80.93%-3.2M | ---- | 3.23%-1.77M | ---- | 19.95%-1.83M | ---- | -73.33%-2.28M |
Attributable subsidiary (profit) loss | ---- | -180.27%-33.12M | ---- | 771.93%41.26M | ---- | -144.17%-6.14M | ---- | ---2.52M | ---- | ---- |
Impairment and provisions: | ---- | 136.95%481K | ---- | -93.24%203K | ---- | 316.78%3.01M | ---- | -88.34%721K | ---- | 251.39%6.18M |
-Impairmen of inventory (reversal) | ---- | -46.90%1.3M | ---- | --2.45M | ---- | ---- | ---- | ---- | ---- | ---- |
-Impairment of trade receivables (reversal) | ---- | 63.52%-819K | ---- | -174.71%-2.25M | ---- | 316.78%3.01M | ---- | -88.34%721K | ---- | 251.39%6.18M |
Asset sale loss (gain): | ---- | -1,161.43%-6.69M | ---- | -74.17%630K | ---- | 634.87%2.44M | ---- | 73.63%-456K | ---- | -9.78%-1.73M |
-Available for sale investment sale loss (gain) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 48.05%-80K |
-Loss (gain) on sale of property, machinery and equipment | ---- | -430.77%-4.61M | ---- | -76.00%1.39M | ---- | 212.76%5.81M | ---- | 389.70%1.86M | ---- | 54.89%-641K |
-Loss (gain) from selling other assets | ---- | -171.73%-2.08M | ---- | 77.32%-764K | ---- | -45.65%-3.37M | ---- | -129.46%-2.31M | ---- | ---1.01M |
Depreciation and amortization: | ---- | -6.79%525.18M | ---- | -0.96%563.46M | ---- | 3.04%568.92M | ---- | 11.30%552.16M | ---- | 39.76%496.11M |
-Amortization of intangible assets | ---- | -5.72%7.61M | ---- | -18.66%8.08M | ---- | 0.41%9.93M | ---- | 6.62%9.89M | ---- | 5.71%9.27M |
Financial expense | ---- | 14.79%336.96M | ---- | 96.83%293.53M | ---- | 20.70%149.13M | ---- | -24.11%123.56M | ---- | 80.54%162.82M |
Special items | ---- | --39.43M | ---- | ---- | ---- | 533.66%61.09M | ---- | --9.64M | ---- | ---- |
Operating profit before the change of operating capital | ---- | -25.15%1.01B | ---- | -3.02%1.35B | ---- | 68.38%1.39B | ---- | -15.01%827.98M | ---- | 30.58%974.2M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 146.39%162.16M | ---- | 121.73%65.82M | ---- | -130.90%-302.92M | ---- | 45.83%-131.19M | ---- | -133.27%-242.17M |
Accounts receivable (increase)decrease | ---- | -177.55%-327.93M | ---- | 1,165.48%422.84M | ---- | 89.14%-39.69M | ---- | -543.40%-365.5M | ---- | 303.13%82.43M |
Accounts payable increase (decrease) | ---- | 124.56%72.69M | ---- | -2,597.87%-295.97M | ---- | -91.08%11.85M | ---- | 529.26%132.84M | ---- | -38.61%-30.95M |
prepayments (increase)decrease | ---- | -58.08%-44.35M | ---- | -77.96%-28.06M | ---- | -268.69%-15.77M | ---- | -14.03%-4.28M | ---- | 90.79%-3.75M |
Special items for working capital changes | ---- | ---- | ---- | ---- | ---- | --3.91M | ---- | ---- | ---- | ---- |
Cash from business operations | 18.93%490.61M | -41.97%878.83M | -58.25%412.54M | 44.01%1.51B | 129.91%988.1M | 128.68%1.05B | 525.18%429.78M | -41.03%459.85M | -85.03%68.75M | 30.04%779.76M |
Other taxs | 95.10%-6.47M | -3,067.28%-131.85M | -4,938.60%-132.11M | 81.56%-4.16M | 62.10%-2.62M | -49.13%-22.58M | -173.11%-6.92M | 53.29%-15.14M | 3,554.01%9.46M | 11.05%-32.41M |
Net cash from operations | 72.65%484.14M | -50.54%746.98M | -71.54%280.42M | 46.77%1.51B | 133.05%985.47M | 131.39%1.03B | 440.68%422.86M | -40.50%444.71M | -82.96%78.21M | 32.70%747.35M |
Cash flow from investment activities | ||||||||||
Interest received - investment | -40.31%770K | -26.78%2.34M | -8.45%1.29M | 80.93%3.2M | 53.99%1.41M | -3.23%1.77M | -15.59%915K | -19.95%1.83M | -15.25%1.08M | 73.33%2.28M |
Dividend received - investment | ---- | 234.10%19.21M | --19.21M | --5.75M | ---- | ---- | ---- | ---- | ---- | ---- |
Decrease in deposits (increase) | ---- | ---- | ---- | ---- | -79.67%1.2M | ---- | --5.89M | ---6.91M | ---- | ---- |
Sale of fixed assets | -26.50%2.13M | 1,373.44%34.73M | 209.86%2.89M | -78.08%2.36M | -65.89%933K | 356.49%10.76M | -46.14%2.74M | -1.05%2.36M | 155.95%5.08M | 58.00%2.38M |
Purchase of fixed assets | 3.93%-213.8M | 13.90%-375.91M | 11.33%-222.55M | 10.92%-436.59M | 32.34%-250.99M | 21.75%-490.1M | -23.28%-370.94M | 23.26%-626.29M | 29.97%-300.88M | 29.91%-816.08M |
Selling intangible assets | ---- | --103K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Purchase of intangible assets | 45.58%-2.08M | -2,019.14%-62.9M | 41.57%-3.83M | 95.53%-2.97M | 89.77%-6.55M | -80.88%-66.45M | -408.44%-64.01M | -365.93%-36.74M | 72.00%-12.59M | 113.54%13.81M |
Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | --89.39M | ---- | ---- | ---- | ---- |
Acquisition of subsidiaries | ---- | ---- | ---- | ---352.46M | ---352.46M | ---- | ---- | ---- | ---- | ---- |
Recovery of cash from investments | 81.69%1.07M | -33.63%590K | -26.07%590K | -74.23%889K | --798K | --3.45M | ---- | ---- | ---- | -59.74%686K |
Cash on investment | 19.65%-5.54M | 87.02%-11.48M | 91.77%-6.89M | -654.90%-88.44M | -1,111.94%-83.71M | 77.42%-11.72M | 85.33%-6.91M | -5.76%-51.87M | -7.12%-47.08M | -298.07%-49.05M |
Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---9.2M | ---11.5M | ---- |
Net cash from investment operations | -3.90%-217.45M | 54.70%-393.31M | 69.64%-209.29M | -87.57%-868.26M | -59.46%-689.37M | 36.31%-462.9M | -18.15%-432.32M | 14.08%-726.82M | 25.03%-365.89M | 31.26%-845.96M |
Net cash before financing | 274.91%266.69M | -44.91%353.66M | -75.98%71.14M | 13.40%641.97M | 3,231.01%296.1M | 300.66%566.1M | 96.71%-9.46M | -186.09%-282.11M | -892.55%-287.68M | 85.23%-98.61M |
Cash flow from financing activities | ||||||||||
New borrowing | -31.38%1.7B | 102.92%3.64B | 18.97%2.48B | -40.96%1.8B | -18.23%2.09B | 24.92%3.04B | 105.72%2.55B | 10.86%2.43B | 17.16%1.24B | -4.21%2.2B |
Refund | 28.66%-1.7B | -64.12%-3.45B | -3.74%-2.39B | 33.22%-2.1B | 12.33%-2.3B | -90.02%-3.15B | -323.70%-2.63B | -1.56%-1.66B | 27.18%-620.04M | -14.89%-1.63B |
Interest paid - financing | -12.86%-169.16M | -15.06%-327.53M | -2.54%-149.89M | -90.88%-284.66M | -127.41%-146.18M | -18.10%-149.13M | -0.47%-64.28M | 22.44%-126.28M | 17.40%-63.98M | -80.54%-162.82M |
Dividends paid - financing | ---- | 66.24%-64.89M | ---- | -35.34%-192.21M | ---- | -190.00%-142.01M | ---- | 48.72%-48.97M | 0.00%-48.97M | -5.41%-95.49M |
Net cash from financing operations | -106.84%-188.57M | 70.93%-251.56M | 76.91%-91.17M | -88.00%-865.38M | -114.82%-394.84M | -190.10%-460.31M | -138.87%-183.8M | 118.52%510.88M | 1,136.10%472.81M | -66.26%233.79M |
Effect of rate | 101.81%3.51M | -59.45%-154.01M | -702.96%-194.15M | -257.68%-96.59M | -1,924.83%-24.18M | 427.97%61.26M | 114.16%1.33M | 182.87%11.6M | -22.05%-9.36M | -52.15%-14M |
Net Cash | 489.95%78.12M | 145.70%102.1M | 79.71%-20.03M | -311.18%-223.41M | 48.91%-98.74M | -53.76%105.79M | -204.39%-193.25M | 69.23%228.76M | 1,897.95%185.13M | 429.85%135.18M |
Begining period cash | -7.69%623.12M | -32.16%675.03M | -32.16%675.03M | 20.18%995.03M | 20.18%995.03M | 40.90%827.98M | 40.90%827.98M | 25.98%587.62M | 25.98%587.62M | 3.62%466.44M |
Cash at the end | 52.92%704.74M | -7.69%623.12M | -47.16%460.85M | -32.16%675.03M | 37.11%872.11M | 20.18%995.03M | -16.68%636.05M | 40.90%827.98M | 63.10%763.39M | 25.98%587.62M |
Cash balance analysis | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.